J B Chemicals & Pharmaceuticals has allotted 31,160 equity shares under ESOS on 19 February 2026. Consequently, the issued, subscribed and paid-up capital has increased from 16,05,27,546 equity shares of Re. 1 each to 16,05,58,706 equity shares of Re. 1 each. Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 5 February 2026, inter alia, have recommended the interim dividend of Rs 12.7 per equity Share (i.e. 1270%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live News

J B Chemicals & Pharmaceuticals has allotted 37,84,100 equity shares under ESOS on 21 January 2026. Consequently, the issued, subscribed and paid-up capital has increased from 15,66,50,956 equity shares of Re. 1 each to 16,04,35,056 equity shares of Re. 1 each. Powered by Capital Market - Live News

Net profit of J B Chemicals & Pharmaceuticals rose 21.79% to Rs 197.89 crore in the quarter ended December 2025 as against Rs 162.49 crore during the previous quarter ended December 2024. Sales rose 10.51% to Rs 1064.72 crore in the quarter ended December 2025 as against Rs 963.49 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales1064.72963.49 11 OPM %27.7826.42 - PBDT312.22259.93 20 PBT266.87217.99 22 NP197.89162.49 22 Powered by Capital Market - Live News